The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and CNS progression analysis from the randomized phase 2 trial of neratinib + paclitaxel vs trastuzumab + paclitaxel as first-line treatment for HER2+ metastatic breast cancer (NEfERTT).
 
Ahmad Awada
Consulting or Advisory Role - Bayer; Roche Pharma AG
 
Ramon Colomer
Consulting or Advisory Role - Roche Pharma AG
Travel, Accommodations, Expenses - Roche Pharma AG
 
Igor Bondarenko
No Relationships to Disclose
 
Kenichi Inoue
Research Funding - Chugai Pharma; Daiichi Sankyo; Parexel
 
Rajendra A. Badwe
No Relationships to Disclose
 
Georgia Demetriou
Consulting or Advisory Role - Amgen; Bayer; Novartis; Pfizer; Sanofi
Travel, Accommodations, Expenses - Roche Pharma AG
 
Xiaojia Wang
No Relationships to Disclose
 
Vitaly Smirnov
No Relationships to Disclose
 
Soo-Chin Lee
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - GlaxoSmithKline
Travel, Accommodations, Expenses - Roche Pharma AG
 
Ajay O. Mehta
No Relationships to Disclose
 
Sung-Bae Kim
Research Funding - Novartis
 
Zhen-Zhou Shen
No Relationships to Disclose
 
Thomas Denis Bachelot
Honoraria - Novartis; Roche Pharma AG
Consulting or Advisory Role - Novartis; Roche Pharma AG; SERVIER
Research Funding - Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Novartis; Roche Pharma AG
 
Chanchal Goswami
No Relationships to Disclose
 
S. V. S. Deo
No Relationships to Disclose
 
Ron Bose
Honoraria - Genentech; Novartis; Reinsurance Group of America
 
Alvin Wong
Employment - Puma Biotechnology
Leadership - Puma Biotechnology
Stock and Other Ownership Interests - Gilead Sciences; Proteolix; Puma Biotechnology
Travel, Accommodations, Expenses - Puma Biotechnology
 
Feng Xu
Employment - Amgen (I); Puma Biotechnology
Stock and Other Ownership Interests - Amgen; Amgen (I)
 
Richard Bryce
Employment - Puma Biotechnology
Leadership - Puma Biotechnology
Stock and Other Ownership Interests - Puma Biotechnology
 
Lisa A. Carey
Research Funding - Genentech/Roche; GlaxoSmithKline